'Tissue factor' presentation slideshows

Tissue factor - PowerPoint PPT Presentation


‘Point-of-Care’ Coagulation Monitors

‘Point-of-Care’ Coagulation Monitors

‘Point-of-Care’ Coagulation Monitors . Evan Pivalizza, M.D. October, 2005. A. Anticoagulation (heparin) management. Function – whole blood clotting Quantitative- heparin level. ACT (Activated clotting time) Hemachron 2 ml blood + activator (celite → kaolin)

By brooke
(181 views)

Coagulation Screening Test

Coagulation Screening Test

Coagulation Screening Test. Mr. Mohammed A. Jabar. PREANALYTICAL VARIABLES INCLUDING SAMPLE COLLECTION .

By lev
(564 views)

Hemostasis, Surgical Bleeding, and Transfusion

Hemostasis, Surgical Bleeding, and Transfusion

Hemostasis, Surgical Bleeding, and Transfusion. Patrick Chidi Obasi. Hemostasis. Complex process that prevents blood loss from disrupted intravascular space. Major physiologic events: Primary hemostasis Vascular constriction Platelet plug formation Secondary hemostasis Fibrin Formation

By bond
(1728 views)

MM Year 2 MCD Part 2

MM Year 2 MCD Part 2

MM Year 2 MCD Part 2. Maheen Ahsan sma114@ic.ac.uk. Haem 9-11: Haemostasis Abnormalities of haemostasis Abnormal white cell count Diagnostics: Chemical Pathology Virology Bacteriology Histopathology and Cytopathology Immunology: Antibodies. Haem LOs. 1. Haemostasis:

By didier
(454 views)

Laboratory Tests for Haemostatic Functions

Laboratory Tests for Haemostatic Functions

Laboratory Tests for Haemostatic Functions. Dr. Mohamed Iqbal Musani, MD. Hemostasis:. BV Injury. Tissue Factor. Neural. Coagulation Activation. Blood Vessel Constriction. Platelet Activation. Primary hemostatic plug. Reduced Blood flow. Plt-Fusion. Thromibn, Fibrin.

By zaza
(232 views)

Pharmacology III (PHL 418)

Pharmacology III (PHL 418)

Pharmacology III (PHL 418). Drugs to Reduce Blood Clotting ( تخثر الدم ). Dr. Mohammad Nazam Ansari. Drugs used to reduce clotting. DVT: Deep venous thrombosis. Thrombus Formation. Arterial formation:

By cutler
(520 views)

Platelet

Platelet

Platelet. Thrombocytes. Platelets (Thrombocytes). 2- 4 micromillimeters in diameter 250,000 – 400,000 per microliter (too few thrombocytopenia – too many thrombocytosis) Lifespan on average 6 – 10 days 1/3 trapped in spleen (for reserve) No significant marrow reserve

By avi
(249 views)

How to handle samples for coagulation analyses

How to handle samples for coagulation analyses

How to handle samples for coagulation analyses. Anne-Mette Hvas Department of Clinical Biochemistry Center for Haemophilia and Thrombosis Aarhus University Hospital, Skejby Denmark. For the next 15 minutes. Preparation of the patient Specimen collection Venipuncture

By JasminFlorian
(84 views)

Recombinant Factor VIIA

Recombinant Factor VIIA

Recombinant Factor VIIA. Sridhar ,V.M.D. Critical Care,Anesthesiology and Cardiology. Introduction. Universal hemostatic agent. Originally developed for treatment of hemophiliac patients. Those with inhibitory antibodies to Factor VIII and Factor IX. Normal Hemostasis.

By huong
(729 views)

Major Hemorrhagic Events (Acute Phase) No significant increase in rate of major hemorrhage

Major Hemorrhagic Events (Acute Phase) No significant increase in rate of major hemorrhage

Major Hemorrhagic Events (Acute Phase) No significant increase in rate of major hemorrhage. 60. Number of patients. NS. UFH. Enoxaparin. 40. NS. NS. 20. 0. ESSENCE n = 3171. TIMI 11B n = 3910. TESSMA n = 7081. UFH, unfractionated heparin; NS, not significant.

By katen
(148 views)

Blood

Blood

Blood. Chapter 10. Composition of Blood. Anemias. Blood Cell Development. Regulation of RBC Formation. Hemostasis. Vascular Spasms –smooth muscle in wall of vessel contracts Platelet Plug Formation –exposed collagen from basement layer of vessel causes platelets to become sticky

By hija
(186 views)

HEMATOLOGIC SYSTEM

HEMATOLOGIC SYSTEM

HEMATOLOGIC SYSTEM. Ch. 14 Goodman. OVERVIEW. *The hematologic system involves the blood, blood vessels and the associated organs. *The study of hematology includes the diseases of the hematological system.

By elton
(264 views)

Cancer-associated Thrombotic Disease

Cancer-associated Thrombotic Disease

Reporter: CR 吳嘉芸 Supervisor: VS 邱宗傑. Cancer-associated Thrombotic Disease. Reporter: CR 吳嘉芸 Supervisor: VS 邱宗傑. Cancer-associated Thrombotic Disease. Outline. History Epidemiology Pathogenesis Thromboprophylaxis. Outline. History Epidemiology Pathogenesis Thromboprophylaxis.

By santos
(85 views)

Haemostasis and thrombosis:

Haemostasis and thrombosis:

Haemostasis and thrombosis:. Thrombosis is the formation of a clotted mass of blood within the cardiovascular system. Continued……. It involves the interaction of blood vessel wall, formed elements of blood and coagulation system

By elia
(396 views)

Pharmacological Methods to Reduce Blood Loss in Surgery

Pharmacological Methods to Reduce Blood Loss in Surgery

Pharmacological Methods to Reduce Blood Loss in Surgery. George Despotis, MD Associate Professor of Anesthesiology, Pathology and Immunology Department of Anesthesiology and Blood Bank Washington University School of Medicine St. Louis, Missouri.

By elia
(125 views)

Program Information

Program Information

Program Information. Venous Thromboembolism (VTE) in ICU. Chee M. Chan, MD Pulmonary and Critical Care Medicine Washington Hospital Center Washington, D.C. VTE in ICU. Pathophysiology of thrombosis Prophylaxis and DVT Pathophysiology of pulmonary embolism Pulmonary embolism diagnostics

By viet
(250 views)

Hemostasis

Hemostasis

Hemostasis. platelet plug formation vasoconstriction blood coagulation. Platelet Formation. Fig. 18.20. Fig. 27-2 Ganong. Platelet Activation and Platelet Plug Formation. Fig. 18.21. Coagulation Mechanisms. Fig. 18.23. Common Mechanism. Fig. 18.23. Fig. 18.22. Extrinsic Mechanism.

By tasha
(223 views)

Doc. Dr Zvezdana Kojić Decembar 2004.

Doc. Dr Zvezdana Kojić Decembar 2004.

Biolo ški mehanizmi regulacija - Fiziologija kardiovaskularnog sistema -. Aterogeneza: značaj lipidskih poremećaja i oksidativnog stresa. Novi faktori rizika za ishemijsku bolest srca. Doc. Dr Zvezdana Kojić Decembar 2004. Atherosclerosis: a multifactorial disease.

By hedda
(177 views)

D isseminated I ntravascular C oagulation DIC

D isseminated I ntravascular C oagulation DIC

D isseminated I ntravascular C oagulation DIC. Doç.Dr. Tiraje Celkan. DIC DEATH is COMING. An acquired syndrome characterized by systemic intravascular coagulation Coagulation is always the initial event. Most morbidity and mortality depends on extent of intravascular thrombosis

By darryl
(109 views)

Introduction

Introduction

Soluble tissue factor in Primary HIV Infection. Elizabeth Hamlyn 1,2 , Kiran Parmar 3 , Stephen Hickling 4 , John Frater 4 , Rodney Phillips 4 , Myra McClure 1 , Sarah Fidler 1 , and Beverley J Hunt 3 for the SPARTAC Investigators

By nitza
(136 views)

View Tissue factor PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Tissue factor PowerPoint presentations. You can view or download Tissue factor presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.